Entropy Neurodynamics (ENP.AX) Stock Price

Entropy Neurodynamics Price

ASX·CLOSED
0.04
​
Market closed

Revenue has compounded at 151.6% per year over the past 3 years to 1.59 M AUD. Entropy Neurodynamics's net margin stands at -335.9%, up from -10,111.3% several years earlier.

Entropy Neurodynamics stock price

Access this data via the Eulerpool API

Entropy Neurodynamics business model & stock analysis

Exopharm Ltd. engages in the development and commercialization of exosomes as therapeutic agents. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-12-18. The firm invests in biopharmaceutical drug development. The firm is engaged in exosome technology and holds a portfolio of intellectual property and know-how related to exosomes and the manufacture of exosomes. The Company’s exosome technologies solve needs for the success of exosome medicines, LEAP manufacturing technology, LOAD API loading technologies and EVPS tropism technologies. The firm is making its proprietary technologies available to pharmaceutical and biotechnology companies that want to harness exosome delivery for their own products.

Frequently asked questions about Entropy Neurodynamics

7 analysts currently rate the Entropy Neurodynamics stock: 0 recommend buying, 3 holding and 4 selling.

Converted at the current exchange rate, the Entropy Neurodynamics share trades at 0.02 EUR (0.04 AUD).

The Entropy Neurodynamics share (ENP.AX) is listed on 1 stock exchanges, including: ASX (EX1.AX).

The revenue cannot currently be calculated for Entropy Neurodynamics.

The profit of Entropy Neurodynamics is -4.87 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Entropy Neurodynamics is currently -13.12. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Entropy Neurodynamics stock.

The P/S cannot be calculated for Entropy Neurodynamics currently.

The Eulerpool Quality Score for Entropy Neurodynamics is 2/10.

The ISIN of Entropy Neurodynamics is AU0000433583. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Entropy Neurodynamics is ENP.AX. The ticker symbol is used to trade Entropy Neurodynamics shares on the stock exchange.

Fair ValueTerminal
0.03 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website exopharm.com
Country
Australia
Currency
AUD
Initial public offering
Dec 18, 2018
ISIN
AU0000433583
Cusip
Q3658N100
Market capitalization
59.43 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
8.07
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-66.12 %
Last updated Oct 8, 2026, 3:30 AM

Entropy Neurodynamics Peer Group

Entropy Neurodynamics Ticker

ASX · EX1.AX